Skip Navigation

Cardiovascular Research 2003 59(2):441-449; doi:10.1016/S0008-6363(03)00435-8
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Reffelmann, T.
Right arrow Articles by Kloner, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reffelmann, T.
Right arrow Articles by Kloner, R. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation

Thorsten Reffelmann and Robert A. Kloner*

The Heart Institute, Good Samaritan Hospital, University of Southern California, 1225 Wilshire Boulevard, Los Angeles, CA 90017-2395, USA

* Corresponding author. Tel.: +1-213-977-4050; fax: +1-213-977-4107. rkloner{at}goodsam.org

Objective: Adverse cardiac events in patients treated with the phosphodiesterase-5 inhibitor sildenafil for erectile dysfunction raised concerns about its safety in ischemic heart disease. Methods: In anesthetized open-chest rabbits, receiving 1.45 mg/kg sildenafil intravenously or saline 30 min prior to ischemia (n = 12, each), infarct size (IS, triphenyltetrazolium), the area of no-reflow (ANR, thioflavin S) (% of the risk area, RA, blue dye), and regional myocardial blood flow (RMBF, radioactive microspheres) were measured after 30 min of coronary occlusion and 180 min of reperfusion. Left ventricular hemodynamics and dimensions (echocardiography) were determined in a separate series of animals (n = 5, each). Results: Sildenafil significantly lowered arterial blood pressure before occlusion (–17 to –19 mmHg over 30 min), but during ischemia and reperfusion hemodynamics were comparable to controls. IS in treated animals (51±4%) did not significantly differ from control animals (47±4%). No major arrhythmias or lengthening of QT/QTc occurred. While sildenafil slightly increased RMBF and significantly reduced specific vascular resistance in the RA during reperfusion (51±7 versus 73±10 mmHg g min/ml, P<0.05), the ANR (46±3%) was similar to control animals (44±4%). Sildenafil reduced left ventricular dP/dtmax (P<0.05) and dP/dtmin (P<0.01) in non-ischemic conditions, and slightly during ischemia, along with a pronounced decrease in ischemic left ventricular end-diastolic pressure (9±2 versus 15±2 mmHg after saline, P<0.05), but did not attenuate acute ischemic left ventricular dilation. Conclusions: Sildenafil reduced cardiac pre- and afterload, and parameters of left ventricular contractility. Myocardial necrosis and microvascular dysfunction were neither exacerbated nor attenuated.

KEYWORDS Coronary circulation; Hemodynamics; Infarction; Reperfusion; Regional blood flow


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
R. A. Kloner
Erectile Dysfunction: The New Harbinger for Major Adverse Cardiac Events in the Diabetic Patient
J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2051 - 2052.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.